This message was sent to ##Email##
|
|
|
|
|
Join the American Society of Transplantation (AST), the European Society for Organ Transplantation (ESOT), and The Transplantation Society (TTS) for the International Transplantation Science (ITS) meeting in Clearwater Beach, Florida.
Transplantation was founded on the spirit of innovation and experimentation. The AST created the Innovation Award to honor an individual or team whose big ideas and outside the box thinking has made a significant impact on transplantation. The award is designed to showcase successes in transplant innovation and to drive, recognize, and reward novel ideas.
READ MORE
The AST Board of Directors has approved the Psychosocial Community of Practice (PSCOP) to change its name to include Ethics as the Psychosocial and Ethics Community of Practice (PSECOP). This resulted from a proposal during the PSCOP annual meeting at ATC as a possible way to increase the profile and membership of the COP and to broaden its scope. There is currently not an obvious COP home for providers who are interested in the ethical issues that arise within the field of transplantation. Learn more about the newly named Psychosocial and Ethics Community of Practice (PSECOP) here.
 |
|
Promoted by
Veloxis Pharmaceuticals
Explore some of the many factors that can put a graft at risk, including CYP3A5*1 expression, declining adherence, and nephrotoxicity. In addition, review pharmacokinetic and clinical data that may be relevant to your practice and patients.
See the Video
|
|
The AST awards annual career development grants for young investigators. Learn more about our research grant opportunities on our website. Please note that a revision has been made that clarifies applicant's clinical time.
READ MORE
The Transplant Nephrology Core Curriculum (TNCC) is an online program jointly provided by the American Society of Nephrology and the American Society of Transplantation. The TNCC focuses on key information needed to prepare for the American Board of Internal Medicine Nephrology Board Certification and Maintenance of Certification examinations.
READ MORE
Advertisement
Veloxis Pharmaceuticals
Explore this phase 3 randomized, double-blind, double-dummy, multicenter, multinational, non-inferiority trial published in the American Journal of Transplantation. The study examined treatment failures defined as BPAR, graft failure, death, and delayed graft function at 3 months and 12 months.
Explore data
|
AST
Comprehensive Trainee Curriculum (CTC) is a great way to expand your transplant knowledge. This feature is an online educational platform that features dozens of webinars on various concentrations of transplantation.
READ MORE
The Career Center connects hiring organizations and transplant professionals searching for career opportunities. AST members with openings to fill can post them here. You can also be one of the first to see new postings by following the AST Career Center on Twitter.
| Upcoming Education Events
|
    |
October 2, 2019 | 2 pm ET | Online Activity
October 15, 2019 | 4 pm ET | Online Activity
October 31, 2019 | 2 pm ET | Online Activity
|
|
ASN
Join ASN, AST, and more than 13,000 other kidney professionals from across the globe at ASN Kidney Week 2019 in San Diego, CA. The world's premier nephrology meeting, Kidney Week provides participants exciting and challenging opportunities to exchange knowledge, learn the latest scientific and medical advances, and listen to engaging and provocative discussions with leading experts in the field. Learn about the Kidney Transplantation Early Program (Oct 23 – Oct 24).
AASLD
A high proportion of patients develop chronic kidney disease after liver transplantation. We aimed to develop clinical/protein models to predict future GFR deterioration in this population. In independent multicenter discovery (CTOT14) and single center validation (BUMC) cohorts, we analyzed kidney injury proteins in serum/plasma samples at month 3 after liver transplant in recipients with preserved GFR who demonstrated subsequent GFR deterioration vs. preservation by year 1, and year 5 in the BUMC cohort.
READ MORE
|
KidneyCare combines clinically validated AlloSure testing with AlloMap kidney and iBox to deliver personalized and Prognostic solutions for transplant patients.
Learn More
|
|
|
|
|
TruGraf® - The 1st and only non-invasive test to rule out “silent" subclinical rejection in stable kidney transplant recipients
The only test to be reimbursed as an alternative to surveillance biopsies
Developed by Clinicians for Clinicians
Learn More
|
|
|
|
|
AASLD
In patients with end‐stage liver disease, the ability to predict recovery of renal function following liver transplantation (LT) remains elusive. However, several important clinical decisions depend on whether renal dysfunction is recoverable after LT.
READ MORE
The Lancet
Low donor heart availability underscores the need to identify all potentially transplantable organs. We sought to determine whether pre-emptive administration of pangenotypic direct-acting antiviral therapy can safely prevent the development of chronic hepatitis C virus (HCV) infection in uninfected recipients of HCV-infected donor hearts.
READ MORE
|
Advertisement
|
Join us as we explore a groundbreaking technology with the only advanced biopsy service that provides objective data for personalized transplant care. The Molecular Microscope® Diagnostic System (MMDx) is now paving the way for the development of precision immunosuppression based on big data analysis by providing a new understanding of graft injury and rejection. Register Now
|
|
|
|
|
Reach Your Prospects Every Week
Thousands of industry professionals subscribe to association news briefs, which allows your company to push messaging directly to their inboxes and take advantage of the association's brand affinity.
Connect with Highly Defined Buyers and Maximize Your Brand Exposure
|
|
|
|
|
JAMA
For-profit (vs nonprofit) dialysis facilities have historically had lower kidney transplantation rates, but it is unknown if the pattern holds for living donor and deceased donor kidney transplantation, varies by facility ownership, or has persisted over time in a nationally representative population.
READ MORE
AJT
Although neutropenia is a common complication following lung transplantation, its relationship to recipient outcomes remains understudied. We evaluated a retrospective cohort of 228 adult lung transplant recipients between 2008 and 2013 to assess the association of neutropenia and Granulocyte Colony Stimulating Factor (GCSF) treatment with outcomes.
READ MORE
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
